NAT1 antibody

Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
NAT1 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab05560
tested applications
ELISA, WB, IHC, FC,IF

Description

Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
N-acetyltransferase 1(arylamine N-acetyltransferase) (NAT1)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1:500-1:1000; IHC: 1:20-1:200; IF: 1:20-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
34 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IHC, FC,IF
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
P18440
Gene ID
9
Alias
Arylamine N-acetyltransferase 1,Arylamide acetylase 1,Monomorphic arylamine N-acetyltransferase (MNAT),N-acetyltransferase type 1 (NAT-1),NAT1,AAC1
Background
Antibody anti-NAT1
Status
RUO
Note
Mol. Weight 34 kDa

Descripción

Related Products

FNab05560

NAT1 antibody

Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.

Ver Producto
FNab05561

NAT1 antibody

Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.

Ver Producto
FNab09978

NAT1 antibody

Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.

Ver Producto